FDA orders GlaxoSmithKline to stop signing up new patients for a big study that it figures would settle questions about the diabetes drug Avandia's risks.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/07/21/128669560/fda-halts-enrollment-in-avandia-safety-trial?ft=1&f=103537970
Posted
Jul 21 2010, 10:36 AM
by
NPR Blogs: Shots - Health News Blog